General Information of Drug Transporter (DT)
DT ID DTD0164 Transporter Info
Gene Name SLC24A3
Transporter Name Sodium/potassium/calcium exchanger 3
Gene ID
57419
UniProt ID
Q9HC58
Post-Translational Modification of This DT
Overview of SLC24A3 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC24A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

71

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC24A3 Asparagine 71 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC24A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

86

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC24A3 Asparagine 86 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC24A3 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

39

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Serine 39 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC24A3 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

41

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Serine 41 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC24A3 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

42

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Serine 42 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC24A3 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

288

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Serine 288 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC24A3 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

308

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Serine 308 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC24A3 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

361

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Serine 361 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC24A3 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

294

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Threonine 294 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC24A3 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

365

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Threonine 365 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC24A3 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

398

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Threonine 398 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC24A3 [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

364

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC24A3 Tyrosine 364 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: NCKX3_HUMAN)
2 Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability. Mol Biol Cell. 2018 May 1;29(9):1031-1047.
3 Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
4 Reactive Oxygen Species (ROS)-Activated ATM-Dependent Phosphorylation of Cytoplasmic Substrates Identified by Large-Scale Phosphoproteomics Screen. Mol Cell Proteomics. 2016 Mar;15(3):1032-47.
5 Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
6 Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
7 Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
8 Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
9 Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.